Literature DB >> 6137018

Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.

R Friedman, R J Barrett, E Sanders-Bush.   

Abstract

The purpose of the present studies was to investigate further the role of central serotonin (5-HT) in mediating the L-5-hydroxytryptophan (L-5-HTP) discriminative cue. Rats were trained to discriminate the stimulus properties of 35 mg/kg L-5-HTP combined with RO 4-4602, a peripheral decarboxylase inhibitor. Considering that several 5-HT antagonists were unable to block the L-5-HTP discriminative cue in our earlier studies, we extended these studies to include the two other presumed 5-HT antagonists mianserin and BC-105 (pizotyline). Only BC-105 completely blocked the training dose of L-5-HTP. Furthermore, the blockade of the L-5-HTP cue was both graded and surmountable by increasing the dose of L-5-HTP, suggesting a competitive antagonism. In neurochemical studies, the regional brain levels of 5-HT, norepinephrine and dopamine were determined after the injection of the training dose of L-5-HTP. Marked changes in the levels of 5-HT were found, while the levels of the catecholamines were changed only slightly or not at all. Furthermore, dose-response studies of L-5-HTP demonstrated an orderly dose-related increase in the levels of 5-HT in brain and in the percent responding on the L-5-HTP lever, while no such relationship was found for brain catecholamines. These results agree with previous pharmacological studies and suggest that the L-5-HTP discrimination is mediated by a central 5-HT receptor that has pharmacological properties distinct from those receptors identified in previous behavioral models of 5-HT receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137018     DOI: 10.1007/bf00436154

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.

Authors:  P Bedard; C J Pycock
Journal:  Neuropharmacology       Date:  1977-10       Impact factor: 5.250

2.  Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input.

Authors:  H J Haigler; G K Aghajanian
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

3.  In vivo determination of endogenous biogenic amines in rat brain using HPLC and push-pull cannula.

Authors:  C C Loullis; J N Hingtgen; P A Shea; M H Aprison
Journal:  Pharmacol Biochem Behav       Date:  1980-06       Impact factor: 3.533

4.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

Review 5.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

Authors:  S Herling; J H Woods
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

6.  Pharmacological profile of a model for central serotonin receptor activation.

Authors:  W D Matthews; C D Smith
Journal:  Life Sci       Date:  1980-04-28       Impact factor: 5.037

7.  Postsynaptic action by four antidepressive drugs in an animal model of depression.

Authors:  H Nagayama; J N Hingtgen; M H Aprison
Journal:  Pharmacol Biochem Behav       Date:  1981-07       Impact factor: 3.533

8.  Stimulus properties of opioids with mixed agonist and antagonist activity.

Authors:  S G Holtzman
Journal:  Fed Proc       Date:  1982-05

9.  Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.

Authors:  R J Barrett; M A Blackshear; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  The noradrenaline receptor coupled adenylate cyclase system in brain. Lack of modification by changes in the availability of serotonin.

Authors:  R Mishra; N J Leith; L Steranka; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

View more
  4 in total

1.  Discriminative stimulus properties of the serotonin agonist MK 212.

Authors:  K A Cunningham; P M Callahan; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.

Authors:  Anne Dekeyne; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

4.  Antagonism by ketanserin of the behavioral effects of quipazine but not l-5-hydroxytryptophan in squirrel monkeys.

Authors:  J M Witkin; L S Brady; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.